Most Popular Articles : International Clinical Psychopharmacology

Secondary Logo

Journal Logo

Most Popular Articles

Clinical advances in obsessive-compulsive disorder: a position statement by the International College of Obsessive-Compulsive Spectrum Disorders

Fineberg, Naomi A.; Hollander, Eric; Pallanti, Stefano; More

International Clinical Psychopharmacology. 35(4):173-193, July 2020.

Reduced sexual dysfunction with aripiprazole once-monthly versus paliperidone palmitate: results from QUALIFY

Potkin, Steven G.; Loze, Jean-Yves; Forray, Carlos; More

International Clinical Psychopharmacology. 32(3):147-154, May 2017.

Body dysmorphic disorder: a treatment synthesis and consensus on behalf of the International College of Obsessive-Compulsive Spectrum Disorders and the Obsessive Compulsive and Related Disorders Network of the European College of Neuropsychopharmacology

Castle, David; Beilharz, Francesca; Phillips, Katharine A.; More

International Clinical Psychopharmacology. 36(2):61-75, March 2021.

Optimal treatment for obsessive compulsive disorder: a randomized controlled feasibility study of the clinical-effectiveness and cost-effectiveness of cognitive-behavioural therapy, selective serotonin reuptake inhibitors and their combination in the management of obsessive compulsive disorder

Fineberg, Naomi A.; Baldwin, David S.; Drummond, Lynne M.; More

International Clinical Psychopharmacology. 33(6):334-348, November 2018.

Social withdrawal as a trans-diagnostic predictor of short-term remission: a meta-analysis of five clinical cohorts

Oliva, Vincenzo; Fanelli, Giuseppe; Kasper, Siegfried; More

International Clinical Psychopharmacology. 37(2):38-45, March 2022.

The effectiveness and safety of cariprazine in schizophrenia patients with negative symptoms and insufficient effectiveness of previous antipsychotic therapy: an observational study

Rancans, Elmars; Dombi, Zsófia Borbála; Mátrai, Péter; More

International Clinical Psychopharmacology. 36(3):154-161, May 2021.

A randomized, double-blind study comparing the efficacy and safety of trazodone once-a-day and venlafaxine extended-release for the treatment of patients with major depressive disorder

Fagiolini, Andrea; Albert, Umberto; Ferrando, Laura; More

International Clinical Psychopharmacology. 35(3):137-146, May 2020.

Lamotrigine-induced mania: warning report for the identification of vulnerable populations and expert clinical recommendations for prescription

Anmella, Gerard; Pacchiarotti, Isabella; Hidalgo-Mazzei, Diego; More

International Clinical Psychopharmacology. 37(6):276-278, November 2022.

Satisfaction of immediate or delayed switch to paliperidone palmitate in patients unsatisfied with current oral atypical antipsychotics

Kwon, Jun Soo; Kim, Sung Nyun; Han, Jaewook; More

International Clinical Psychopharmacology. 30(6):320-328, November 2015.

The effects of brexpiprazole and aripiprazole on body weight as monotherapy in patients with schizophrenia and as adjunctive treatment in patients with major depressive disorder: an analysis of short-term and long-term studies

Weiss, Catherine; Weiller, Emmanuelle; Baker, Ross A.; More

International Clinical Psychopharmacology. 33(5):255-260, September 2018.

A randomized, double-blinded, placebo-controlled study to evaluate the efficacy and safety of venlafaxine extended release and a long-term extension study for patients with major depressive disorder in Japan

Higuchi, Teruhiko; Kamijima, Kunitoshi; Nakagome, Kazuyuki; More

International Clinical Psychopharmacology. 31(1):8-19, January 2016.

Role and clinical implications of atypical antipsychotics in anxiety disorders, obsessive-compulsive disorder, trauma-related, and somatic symptom disorders: a systematized review

Albert, Umberto; Carmassi, Claudia; Cosci, Fiammetta; More

International Clinical Psychopharmacology. 31(5):249-258, September 2016.

Differences in the dynamics of serotonin reuptake transporter occupancy may explain superior clinical efficacy of escitalopram versus citalopram

Kasper, Siegfried; Sacher, Julia; Klein, Nikolas; More

International Clinical Psychopharmacology. 24(3):119-125, May 2009.